Publication | Closed Access

TLR-2 and TLR-4 agonists favor expansion of CD4+ T cell subsets implicated in the severity of neuromyelitis optica spectrum disorders

InflammationAutoimmune DiseaseOphthalmologyMedicineT-regulatory CellImmunologyAutoimmunityCd4 T Cell ResponsesImmunologic DiseaseImmunotherapyNeuroimmunologyRegulatory T Cell BiologyTlr-4 Agonists